Genomics

Dataset Information

NF1-depleted ER+ breast cancers are differentially sensitive to CDK4/6 inhibitors


ABSTRACT: NF1-depleted ER+ breast cancers are differentially sensitive to CDK4/6 inhibitors

PROVIDER: PRJNA1143539 | ENA |

REPOSITORIES: ENA